INTERCEPT PHARMACEUTICALS, INC.·4

Feb 3, 4:01 PM ET

Freedberg Jared 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Feb 3, 2023

Insider Transaction Report

Form 4
Period: 2023-02-01
Freedberg Jared
General Counsel and Secretary
Transactions
  • Tax Payment

    Common Stock

    2023-02-01$18.76/sh918$17,22258,756 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.

Documents

1 file
  • 4
    tm235329-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT